Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of chromatin in retroviral preintegration complex function. | J Biol Chem | 2025 | 40615040 | PubTator, text mining | PubMed |
| Liquid-liquid phase separation of membrane-less condensates: from biogenesis to function. | Front Cell Dev Biol | 2025 | 40438142 | PubTator, text mining | PubMed |
Bromodomain and Extra-Terminal Family Proteins BRD2, BRD3, and BRD4 Contribute to H19-Dependent Transcriptional Regulation of Cell Adhesion Molecules, Modulating Metastatic Dissemination Program in Prostate Cancer. | Noncoding RNA | 2025 | 40407591 | PubTator, text mining | PubMed |
| CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines. | PLoS One | 2025 | 40378113 | PubTator, text mining | PubMed |
| A Rare Case of Oral-Maxillary NUT (Nuclear Protein in Testis) Carcinoma With Diffuse Osseous Metastasis and Hypercalcemia of Malignancy. | Cureus | 2025 | 40370864 | PubTator, text mining | PubMed |
| BRD4 regulates m6A of ESPL1 mRNA via interaction with ALKBH5 to modulate breast cancer progression. | Acta Pharm Sin B | 2025 | 40370540 | PubTator, text mining | PubMed |
| Integrative Approaches Identify Genetic Determinants of Levodopa Induced Dyskinesia. | Mol Neurobiol | 2025 | 40299300 | PubTator, text mining | PubMed |
| Rep_3 plasmids found in Acinetobacter species that include orfX also harbour dif modules. | Plasmid | 2025 | 40280505 | PubTator, text mining | PubMed |
| Inhibition of bromodomain and extra-terminal (BET) proteins with JQ1 exacerbates acetaminophen-induced hepatotoxicity by altering detoxification pathways and oxidative stress responses. | Chem Biol Interact | 2025 | 40157625 | PubTator, text mining | PubMed |
| Long noncoding RNA as an emerging regulator of endoderm differentiation: progress and perspectives. | Cell Regen | 2025 | 40133743 | PubTator, text mining | PubMed |
| Advancing Understanding and Therapeutic Strategies for NUT Sarcomas: Comprehensive Review of the Literature and Two Cases. | J Immunother Precis Oncol | 2025 | 40070529 | PubTator, text mining | PubMed |
| Biochemical investigations using mass spectrometry to monitor JMJD6-catalysed hydroxylation of multi-lysine containing bromodomain-derived substrates. | RSC Chem Biol | 2025 | 40046450 | PubTator, text mining | PubMed |
| Gut-binding peptides as potential tools to reduce virus binding to honey bee gut surface proteins. | Appl Environ Microbiol | 2025 | 40019274 | PubTator, text mining | PubMed |
| Proteomic analysis reveals chromatin remodeling as a potential therapeutical target in neuroblastoma. | J Transl Med | 2025 | 40011918 | PubTator, text mining | PubMed |
| MAD::NUT Fusion Sarcoma: A Sarcoma Class With NUTM1, NUTM2A, and NUTM2G Fusions and Possibly Distinctive Subtypes. | Mod Pathol | 2025 | 39921028 | PubTator, text mining | PubMed |
| Gene Fusion-Driven Cutaneous Adnexal Neoplasms: An Updated Review Emphasizing Molecular Characteristics. | Am J Dermatopathol | 2025 | 39912629 | PubTator, text mining | PubMed |
| Pulmonary Nuclear protein in Testis (NUT) carcinoma: clinical, molecular characteristics, and treatment strategies. | BMC Cancer | 2025 | 39905380 | PubTator, text mining | PubMed |
| Relative quantification of proteins and post-translational modifications in proteomic experiments with shared peptides: a weight-based approach. | Bioinformatics | 2025 | 39888862 | PubTator, text mining | PubMed |
| Correction to "Development of BromoTag: A "Bump-and-Hole"-PROTAC System To Induce Potent, Rapid, and Selective Degradation of Tagged Target Proteins". | J Med Chem | 2025 | 39838864 | PubTator, text mining | PubMed |
| Botulinum neurotoxins exploit host digestive proteases to boost their oral toxicity via activating OrfXs/P47. | Nat Struct Mol Biol | 2025 | 39838108 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=4